Her2 Amplified News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Her2 Amplified. Real-time updates on events, politics, business and more.

Zanidatamab Elicits Responses in HER2-amplified Advanced Biliary Tract Cancer

June 3, 2023

Zanidatamab generated responses in patients with HER2-amplified, locally advanced, unresectable or metastatic biliary tract cancer who were previously treated with gemcitabine.

United States Department Of Gastrointestinal Medical Oncology Department Of Investigational Therapeutics University Of Texas Md Anderson Cancer Center Gastrointestinal Medical Oncology Investigational Therapeutics

Source: onclive.com

Dr Foote on the Use of Tucatinib Plus Trastuzumab in HER2-Amplified mCRC

April 10, 2023

Micheal Foote, MD, discusses the use of tucatinib plus trastuzumab compared with chemotherapy in the management of HER2-amplified metastatic colorectal cancer.

Michael Foote Memorial Sloan Kettering Cancer Center Metastatic Colorectal Cancer Her2 Amplified Metastatic Colorectal Cancer Mountaineer Study

Source: onclive.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Her2 Amplified News Today

Zanidatamab Elicits Responses in HER2-amplified Advanced Biliary Tract Cancer

Dr Foote on the Use of Tucatinib Plus Trastuzumab in HER2-Amplified mCRC

Explore More Categories